Burkitt's Lymphoma
specificA highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures. It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients. Three morphologic variants are recognized: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma. All cases express the MYC translocation [t(8;14)]. (WHO, 2001)
19
Centers
2
Active Trials
$2M
Cancer Funding
Top Centers for Burkitt's Lymphoma(19)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 71.8 |
| 2 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive High-Volume Research Center | 71.8 |
| 3 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 66.8 |
| 4 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 49.3 |
| 5 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 49.3 |
| 6 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 49.3 |
| 7 | NCI Comprehensive | 49.3 |
| 8 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 49.3 |
| 9 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 49.3 |
| 10 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 49.3 |
| 11 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 49.3 |
| 12 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 49.3 |
| 13 | Cleveland Clinic Cancer CenterCleveland, OH | 49.3 |
| 14 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive | 49.3 |
| 15 | Boston University Cancer CenterBoston, MA | 49.3 |
| 16 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 49.3 |
| 17 | Stony Brook Cancer CenterStony Brook, NY | 49.3 |
| 18 | Penn State Cancer InstituteHershey, PA | 49.3 |
| 19 | University of Cincinnati Cancer CenterCincinnati, OH | 49.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →